NCT03602118View on ClinicalTrials.gov

Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2019

Primary Completion Date

May 1, 2021

Study Completion Date

August 1, 2021

Conditions
Neonatal Seizure
Interventions
DRUG

Phenobarbital Sodium Injection

Phenobarbitone Inj, Phenobarbitone SOD, Phenobarbitone Sodium

Sponsors
All Listed Sponsors
lead

PharPoint Research, Inc.

INDUSTRY